Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 73,000 | 141,000 | 94,000 | 24,000 | 129,000 |
| General And Administrative Expense | 73,000 | 141,000 | 94,000 | 24,000 | 129,000 |
| Other Operating Expenses | 4,000 | 34,000 | 25,000 | 47,000 | 64,000 |
| Operating Expense | 77,000 | 175,000 | 119,000 | 71,000 | 193,000 |
| Operating Income | -77,000 | -175,000 | -119,000 | -71,000 | -193,000 |
| EBIT | 46,000 | -76,000 | -119,000 | -60,000 | -90,000 |
| Interest Expense | 1,000 | 0.00 | -- | 0.00 | 0.00 |
| Interest Expense Non Operating | 1,000 | 0.00 | -- | 0.00 | 0.00 |
| Net Interest Income | -1,000 | 0.00 | -- | 0.00 | 0.00 |
| Other Income Expense | 123,000 | 99,000 | 98,000 | 11,000 | 103,000 |
| Other Non Operating Income Expenses | 1,000 | 2,000 | 2,000 | 5,000 | 8,000 |
| Gain On Sale Of Security | 122,000 | 97,000 | 96,000 | 31,000 | 95,000 |
| Pretax Income | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Tax Effect Of Unusual Items | 18,300 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Income From Continuing Operation Net Minority Interest | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Income Including Noncontrolling Interests | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Income Common Stockholders | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Income | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| EBITDA | 46,000 | -76,000 | -119,000 | -60,000 | -90,000 |
| Normalized EBITDA | -76,000 | -173,000 | -215,000 | -66,000 | -185,000 |
| Basic EPS | 0.00 | 0.00 | 0.00 | -- | -0.01 |
| Diluted EPS | 0.00 | 0.00 | 0.00 | -- | -0.01 |
| Basic Average Shares | 51.3M | 51.3M | 51.3M | -- | 50.9M |
| Diluted Average Shares | 51.3M | 51.3M | 51.3M | -- | 50.9M |
| Total Unusual Items | 122,000 | 97,000 | 96,000 | 6,000 | 95,000 |
| Total Unusual Items Excluding Goodwill | 122,000 | 97,000 | 96,000 | 6,000 | 95,000 |
| Tax Rate For Calcs | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -58,700 | -173,000 | -117,000 | -66,000 | -185,000 |
| Diluted NI Availto Com Stockholders | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Income Continuous Operations | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Non Operating Interest Income Expense | -1,000 | 0.00 | -- | 0.00 | 0.00 |
| Other Gand A | 50,000 | 119,000 | 72,000 | 130,000 | 64,000 |
| Salaries And Wages | 23,000 | 22,000 | 22,000 | -106,000 | 65,000 |
| Total Expenses | 77,000 | 175,000 | 119,000 | 71,000 | 193,000 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 755,000 | 508,000 | 635,000 | 788,000 | 709,000 |
| Cash Cash Equivalents And Short Term Investments | 1.1M | 1.1M | 1.4M | 1.4M | 1.4M |
| Cash Financial | 755,000 | 508,000 | 635,000 | 788,000 | 709,000 |
| Other Short Term Investments | 325,000 | 639,000 | 750,000 | 636,000 | 664,000 |
| Accounts Receivable | 15,000 | 16,000 | 12,000 | 19,000 | 26,000 |
| Receivables | 15,000 | 16,000 | 12,000 | 19,000 | 26,000 |
| Current Assets | 1.1M | 1.2M | 1.4M | 1.4M | 1.4M |
| Net PPE | 5.9M | 5.7M | 5.6M | 5.6M | 5.6M |
| Other Non Current Assets | 401,000 | 406,000 | 350,000 | 350,000 | 329,000 |
| Total Non Current Assets | 6.3M | 6.1M | 6.0M | 6.0M | 5.9M |
| Total Assets | 7.4M | 7.3M | 7.4M | 7.4M | 7.3M |
| Accounts Payable | 9,000 | 21,000 | 20,000 | 37,000 | -- |
| Payables | 9,000 | 21,000 | 20,000 | 37,000 | -- |
| Payables And Accrued Expenses | 9,000 | 21,000 | 20,000 | 62,000 | 35,000 |
| Current Accrued Expenses | 0.00 | 0.00 | 0.00 | 25,000 | -- |
| Current Liabilities | 9,000 | 21,000 | 20,000 | 62,000 | 35,000 |
| Total Non Current Liabilities Net Minority Interest | 326,000 | 330,000 | 337,000 | 337,000 | 316,000 |
| Total Liabilities Net Minority Interest | 335,000 | 351,000 | 357,000 | 399,000 | 351,000 |
| Common Stock | 13.5M | 13.5M | 13.5M | 13.5M | 13.3M |
| Capital Stock | 13.5M | 13.5M | 13.5M | 13.5M | 13.3M |
| Additional Paid In Capital | 41.5M | 41.5M | 41.5M | 41.5M | -- |
| Retained Earnings | -50.4M | -50.5M | -50.4M | -50.4M | -50.4M |
| Gains Losses Not Affecting Retained Earnings | -- | -- | -- | -- | 44.0M |
| Common Stock Equity | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Stockholders Equity | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Total Equity Gross Minority Interest | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Total Capitalization | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Net Tangible Assets | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Tangible Book Value | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Working Capital | 1.1M | 1.1M | 1.4M | 1.4M | 1.4M |
| Invested Capital | 7.0M | 7.0M | 7.0M | 7.0M | 6.9M |
| Share Issued | 51.3M | 51.3M | 51.3M | 51.3M | 50.9M |
| Ordinary Shares Number | 51.3M | 51.3M | 51.3M | 51.3M | 50.9M |
| Long Term Provisions | 326,000 | 330,000 | 337,000 | 337,000 | 316,000 |
| Other Equity Interest | 2.4M | 2.4M | 2.3M | 2.3M | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -94,000 | 28,000 | -148,000 | -150,000 | -100,000 |
| Cash Flow From Continuing Operating Activities | -94,000 | 28,000 | -148,000 | -150,000 | -100,000 |
| Stock Based Compensation | 23,000 | 22,000 | 22,000 | -106,000 | 65,000 |
| Change In Working Capital | -11,000 | -3,000 | -35,000 | 35,000 | -36,000 |
| Changes In Account Receivables | 1,000 | -4,000 | 7,000 | -- | -2,000 |
| Change In Receivables | 1,000 | -4,000 | 7,000 | 7,000 | -2,000 |
| Change In Payables And Accrued Expense | -12,000 | 1,000 | -42,000 | 28,000 | -34,000 |
| Capital Expenditure | -125,000 | -118,000 | -5,000 | -- | -- |
| Purchase Of PPE | -- | -118,000 | -5,000 | -- | -- |
| Net PPE Purchase And Sale | -- | -118,000 | -5,000 | 0.00 | 0.00 |
| Purchase Of Investment | -- | 0.00 | 0.00 | -181,000 | 0.00 |
| Sale Of Investment | 461,000 | -- | -- | -- | -- |
| Net Investment Purchase And Sale | 461,000 | 19,000 | 0.00 | 46,000 | 0.00 |
| Investing Cash Flow | 341,000 | -155,000 | -5,000 | 4,000 | -223,000 |
| Cash Flow From Continuing Investing Activities | 341,000 | -155,000 | -5,000 | 4,000 | -223,000 |
| Financing Cash Flow | -- | -- | -- | 225,000 | 0.00 |
| Cash Flow From Continuing Financing Activities | -- | -- | -- | 225,000 | 0.00 |
| Changes In Cash | 247,000 | -127,000 | -153,000 | 79,000 | -323,000 |
| Beginning Cash Position | 508,000 | 635,000 | 788,000 | 709,000 | 1.0M |
| End Cash Position | 755,000 | 508,000 | 635,000 | 788,000 | 709,000 |
| Free Cash Flow | -219,000 | -90,000 | -153,000 | 73,000 | -323,000 |
| Capital Expenditure Reported | -- | -- | -- | -- | -223,000 |
| Net Foreign Currency Exchange Gain Loss | -4,000 | -- | -- | -1,000 | -3,000 |
| Net Income From Continuing Operations | 45,000 | -76,000 | -21,000 | -60,000 | -90,000 |
| Net Other Investing Changes | 5,000 | -- | -- | -- | -- |
| Operating Gains Losses | -4,000 | -- | -- | -- | -- |
| Proceeds From Stock Option Exercised | -- | -- | -- | 225,000 | 0.00 |
| Sale Of PPE | -- | -- | -5,000 | 0.00 | 0.00 |
| Unrealized Gain Loss On Investment Securities | -147,000 | 92,000 | -114,000 | 3,000 | -36,000 |